课题基金 / 基金详情

Acombined early and late HIV-1 protein-specific exosome-targeted T cell vaccine capable of stimulating HIV-1 specific CD8+ CTL responses in absence of CD4+ T cells and counteracting immune suppression.

Acombined early and late HIV-1 protein-specific exosome-targeted T cell vaccine capable of stimulating HIV-1 specific CD8+ CTL responses in absence of CD4+ T cells and counteracting immune suppression.
早期和晚期 HIV-1 蛋白特异性外泌体靶向 T 细胞疫苗能够在缺乏 CD4 T 细胞的情况下刺激 HIV-1 特异性 CD8 CTL 反应并抵消免疫抑制。
批准号:
182524
负责人:
Xiang Jim
金额:
$6.52万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2009
资助国家:
加拿大
项目状态:
已结题
起止时间:
2009-03-01 至 2010-03-01

项目摘要

项目成果

Xiang Jim的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
CD4+ T cells are required for generation and maintenance of cytotoxic CD8+ T cells playing a critical role in control of human immunodeficiency virus type-1 (HIV-1) proliferation. However, CD4+ T cell depletion usually occurs in acquired immunodeficiency
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Distinct regulation of T cell fate and memory via differentially IL-2- and IL-7-activated mTORC1-KIF13A-M6PR axis and AMPK-FOXO-Eomes pathway
  • 批准号:
    354414
  • 项目类别:
    Operating Grants
  • 资助金额:
    $34.27万
  • 财政年份:
    2016
  • 负责人:
    Xiang Jim
  • 依托单位:
Combined late and early HIV-1 protein-specific exosome-targeted T cell-based vaccine capable of stimulating CTL responses in absence of CD4+ T cell help
  • 批准号:
    275588
  • 项目类别:
    Operating Grants
  • 资助金额:
    $21.48万
  • 财政年份:
    2012
  • 负责人:
    Xiang Jim
  • 依托单位:
海外基金